HER2-positive Metastatic Breast Cancer in Kazakhstan

Clinical trial NCT07593196 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07593196
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Metastatic Breast Cancer

Start date: 2026-05-19
Primary completion: 2026-09-30
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.